31 results
DEFM14C
QSAM
QSAM Biosciences, Inc.
11 Apr 24
Information related to merger
7:10am
similar in size, reputation, and track record for the types of transactions that the Company was considering. The terms provided in the three LOE’s were … and Follow-On Rights, especially in the instance the Company were to be acquired after or prior to the proposed Nasdaq listing;
Reputation, track record
PREM14C
QSAM
QSAM Biosciences, Inc.
1 Apr 24
Preliminary information related to merger
8:32am
, #2 and #3 were all similar in size, reputation, and track record for the types of transactions that the Company was considering. The terms provided … ;
Reputation, track record and recently closed transactions for each of the banks, including the types of investors they historically attracted to fund
8-K
EX-2.1
QSAM
QSAM Biosciences, Inc.
7 Feb 24
QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
9:56pm
as a successor Rights Agent any Person that is not a transfer agent of national reputation or the corporate trust department of a commercial bank.
Section 3.04
S-1/A
kf5wf
10 Mar 22
IPO registration (amended)
9:16am
S-1
i211um
17 Dec 21
IPO registration
4:31pm
8-K
EX-10.01
0qt8bketfiw9ou83pd5
31 Jul 18
Q2Earth Signs Definitive Agreement to Acquire Leading Company
8:30am
10-KT
kfu m02842
14 Apr 16
Annual report (with FYE transition)
12:00am
10-12G/A
iglmgdxd2
4 Jun 14
Registration of securities (amended)
12:00am